Enliven Therapeutics, Inc. (ELVN) earnings
Quarterly and annual ELVN reports and results, each read against the price at its own news timestamp. Back to the ELVN overview →
10 measured ELVN earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Enliven Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.37% | +1.57% | |
| Form 10-Q Enliven Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.23% | -2.60% | |
| Form 10-K Enliven Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +4.86% | |
| Form 10-Q Enliven Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.61% | — | |
| Form 10-Q Enliven Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.08% | -0.85% | |
| Form 10-Q Enliven Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -5.20% | -8.33% | |
| Form 10-K Enliven Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.42% | -1.71% | |
| Form 10-Q Enliven Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.27% | -5.53% | |
| Form 10-Q Enliven Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.50% | -2.85% | |
| Enliven Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update | Press release | +0.00% | -1.56% |
Keep exploring
More ELVN: analyst actions → · SEC filings → · ELVN overview →